Cost-Effectiveness of Tarlatamab in the Second-Line Treatment of Refractory Small Cell Lung Cancer From a US Perspective [0.03%]
从美国视角看奈拉塔姆单抗治疗二线难治性小细胞肺癌的成本效益分析
Hanrui Zheng,Feng Wen,Bin Wu
Hanrui Zheng
Background: Compared with chemotherapy, tarlatamab significantly prolonged overall survival in patients with extensive-stage small cell lung cancer (ES-SCLC) whose disease progressed during or after platinum-based chemoth...
Transarterial Chemoembolization Combined With Lenvatinib in the Treatment of Intermediate-Stage Hepatocellular Carcinoma With Hypovascular Nodules: A Retrospective Cohort Study [0.03%]
经导管动脉化疗栓塞联合仑伐替尼治疗低血管化结节中期肝细胞癌患者：回顾性队列研究
Jun Yang,Fei Shi,Nan Jiang et al.
Jun Yang et al.
Background: To compare the efficacy and safety of transarterial chemoembolization (TACE) combined with lenvatinib vs TACE alone in intermediate-stage hepatocellular carcinoma (HCC) patients with hypovascular nodules. ...
The Patient Experience of Cancer-Related Cachexia: Implications for Patient-Reported Outcomes Measures [0.03%]
癌症恶病质患者的体验：对患者报告结果测量工具的启示
Magdalena Harrington,Susan Martin,Oyebimpe Olayinka-Amao et al.
Magdalena Harrington et al.
Background: Understanding the patient experience, including symptoms and impacts, of cancer-related cachexia is an important step in developing and validating patient-reported outcome measures that can support the subsequ...
Symptom Burden and Healthcare Resource Use in Patients With Claudin 18.2-Positive, HER2-Negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma: A Retrospective Review [0.03%]
Claudin 18.2阳性、HER2阴性局部晚期不可切除或转移性胃癌或 gastroesophageal junction腺癌患者的症状负担和医疗资源使用：一项回顾性分析
Matheus Sewastjanow-Silva,Mok Oh,Lawrence Chang et al.
Matheus Sewastjanow-Silva et al.
Background: Control of disease-related symptoms is a goal of chemotherapy for patients with locally advanced (LA) unresectable or metastatic gastric/gastroesophageal junction (mG/GEJ) adenocarcinoma. This study describes ...
Retrospective Analysis of the Clinical Efficacy, Safety, and Influencing Factors of Drug-Eluting Bead Transarterial Chemoembolization for Unresectable Hepatic Malignancies [0.03%]
不可切除肝恶性肿瘤载药微球 transcatheter arterial chemoembolization 治疗的疗效、安全性及影响因素的回顾性分析
Li Liu,Yuling Sheng,Xianxian Liang et al.
Li Liu et al.
Background: Transarterial chemoembolization (TACE) is an established therapeutic modality for malignant hepatic tumors. This study assessed the clinical efficacy, adverse events, and factors associated with treatment outc...
Osimertinib for Patients With EGFR-Mutated Non-Small Cell Lung Cancer: Current Evidence [0.03%]
用于表皮生长因子受体突变型非小细胞肺癌患者的奥希替尼：现有证据
Xiumei Tang,Yanmei Chen,Yuan Zhu et al.
Xiumei Tang et al.
Background: Osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, has demonstrated efficacy across multiple treatment lines for patients with EGFR-mutated non-small cell lung c...
Stage Migration and Validity of the International Federation of Gynecology and Obstetrics (FIGO) 2018 Staging System for Cervical Cancer: A Retrospective Cohort Study From a Tertiary Cancer Center in Nepal [0.03%]
宫颈癌国际妇产科联盟（FIGO）2018年分期系统的阶段迁移和有效性：尼泊尔三级癌症中心的回顾性队列研究
Simit Sapkota,Subhas Pandit,Jeebana Bhandari et al.
Simit Sapkota et al.
Introduction: Cervical cancer remains a major public health concern in low- and middle-income countries, including Nepal. The International Federation of Gynecology and Obstetrics (FIGO) 2018 staging system for cervical c...
PD-1/PD-L1-CXCR3 Coexpression and CXCR3 on Intermediate Monocytes Predict Fibrosis, Leukemic Transformation, and Survival in Egyptian Philadelphia-Negative Myeloproliferative Neoplasms [0.03%]
埃及费城阴性骨髓增殖性肿瘤患者中PD-1/PD-L1-CXCR3共表达及中间型单核细胞表面的CXCR3预测纤维化、白血病转化及生存期
Dalia E Sherief,Rawan Ahmed Elmezien,Nahla Nosair et al.
Dalia E Sherief et al.
Background: Despite established prognostic scores, predicting disease progression in myeloproliferative neoplasms (MPNs) remains challenging, and the role of specific immune cell subsets-particularly the PD-1/PD-L1 axis-i...
Proposing an Optimized Prediction Model for Pancreatic Cancer Based on Mendelian Randomization Analysis of Fibrinogen Levels and Urinary Protein Excretion Rate [0.03%]
基于纤维蛋白原水平和尿蛋白排泄率的孟德尔随机化分析的胰腺癌优化预测模型的建立与应用研究
Qian Wu,Mengqing Sun,Yan Lin et al.
Qian Wu et al.
Background: An ongoing debate exists on the relationship between fibrinogen levels, urinary albumin excretion (UAE), and pancreatic ductal adenocarcinoma (PDAC), as demonstrated by clinical data of patients with benign an...
A Population-Specific Ensemble Machine Learning Model for Predicting Borderline or Malignancy Risk of Ovarian Masses in Macao: A Multicenter Retrospective Study [0.03%]
澳门女性卵巢肿物上皮性肿瘤恶性的预测模型的建立及验证：一项多中心回顾性研究
Chan-Fong Chio,Lai-Fong Sin,Hoi-Sun Loi et al.
Chan-Fong Chio et al.
Background: Preoperative discrimination between benign and malignant ovarian tumors is important. The applicability of published prediction tools may be limited across different health systems. We aim to develop a machine...